Phase I/IIa trial of autologous tumor vaccine and temozolomide administration in patients with primary glioblastoma.
Phase of Trial: Phase I/II
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Autologous formalin-fixed tumour cell vaccine (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Therapeutic Use
- 16 Nov 2011 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by University Hospital Medical Information Network - Japan.
- 30 Oct 2009 Additional lead trial investigator identified as reported by University Hospital Medical Information Network - Japan.
- 03 Nov 2008 New trial record.